DK3823588T3 - Farmaceutisk sammensætning i form af en tyggetablet af diosmin eller af en flavonoid del omfattende diosmin - Google Patents

Farmaceutisk sammensætning i form af en tyggetablet af diosmin eller af en flavonoid del omfattende diosmin Download PDF

Info

Publication number
DK3823588T3
DK3823588T3 DK19742363.5T DK19742363T DK3823588T3 DK 3823588 T3 DK3823588 T3 DK 3823588T3 DK 19742363 T DK19742363 T DK 19742363T DK 3823588 T3 DK3823588 T3 DK 3823588T3
Authority
DK
Denmark
Prior art keywords
diosmin
flavonoid
motion
pharmaceutical composition
chewable tablet
Prior art date
Application number
DK19742363.5T
Other languages
English (en)
Inventor
Stephanie Marsas
Jean-Manuel Pean
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK3823588T3 publication Critical patent/DK3823588T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK19742363.5T 2018-07-20 2019-07-19 Farmaceutisk sammensætning i form af en tyggetablet af diosmin eller af en flavonoid del omfattende diosmin DK3823588T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1856769A FR3083980B1 (fr) 2018-07-20 2018-07-20 Composition pharmaceutique sous la forme d'un comprime a croquer de diosmine ou d'une fraction flavonoique
PCT/EP2019/069498 WO2020016408A1 (fr) 2018-07-20 2019-07-19 Composition pharmaceutique sous la forme d'un comprime a croquer de diosmine ou d'une fraction flavonoique

Publications (1)

Publication Number Publication Date
DK3823588T3 true DK3823588T3 (da) 2025-01-02

Family

ID=65243687

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19742363.5T DK3823588T3 (da) 2018-07-20 2019-07-19 Farmaceutisk sammensætning i form af en tyggetablet af diosmin eller af en flavonoid del omfattende diosmin

Country Status (36)

Country Link
EP (2) EP3823588B1 (da)
KR (1) KR20210034036A (da)
CN (2) CN119345141A (da)
AR (1) AR117612A1 (da)
AU (1) AU2019306315B2 (da)
BR (1) BR112021000440A2 (da)
CA (1) CA3106495C (da)
CL (1) CL2021000083A1 (da)
CO (1) CO2021000115A2 (da)
CR (1) CR20210023A (da)
DK (1) DK3823588T3 (da)
EA (1) EA202190269A1 (da)
EC (1) ECSP21001232A (da)
ES (1) ES2991941T3 (da)
FI (1) FI3823588T3 (da)
FR (1) FR3083980B1 (da)
GE (1) GEP20237532B (da)
HR (1) HRP20250037T1 (da)
HU (1) HUE069700T2 (da)
JO (1) JOP20210003A1 (da)
LT (1) LT3823588T (da)
MA (1) MA53159B1 (da)
MD (1) MD3823588T2 (da)
MX (1) MX2021000763A (da)
MY (1) MY200586A (da)
NI (1) NI202100002A (da)
PE (1) PE20210929A1 (da)
PH (1) PH12021550037A1 (da)
PL (1) PL3823588T3 (da)
PT (1) PT3823588T (da)
RS (1) RS66288B1 (da)
SG (1) SG11202100181YA (da)
SI (1) SI3823588T1 (da)
TW (1) TWI831808B (da)
UA (1) UA128677C2 (da)
WO (1) WO2020016408A1 (da)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2661610B1 (fr) * 1990-05-02 1994-09-30 Rhone Poulenc Sante Nouvelle forme lyophilisee de la diosmine et sa preparation.
FR2661830B1 (fr) * 1990-05-11 1992-09-04 Corbiere Jerome Nouvelle compositions pharmaceutiques a base de flavonoside.
FR2726469B1 (fr) 1994-11-08 1996-12-13 Adir Composition pharmaceutique pour l'administration orale de flavonoides
FR2845597B1 (fr) * 2002-10-11 2005-03-11 Innothera Lab Sa Formulation orale seche contenant de la diosmine sous forme pharmaceutique de comprime a croquer
ITMI20050517A1 (it) 2005-03-30 2006-09-30 Therapicon Srl Composizione farmaceutica di una tipica frazione microcristallina di flavonoidi
FR2999934B1 (fr) * 2012-12-21 2015-02-20 Servier Lab Composition pharmaceutique sous la forme d'une suspension orale comprenant une fraction flavonoique et de la gomme xanthane

Also Published As

Publication number Publication date
FR3083980A1 (fr) 2020-01-24
CA3106495A1 (fr) 2020-01-23
MA53159B1 (fr) 2024-12-31
UA128677C2 (uk) 2024-09-25
FR3083980B1 (fr) 2021-04-16
MA53159A (fr) 2021-05-26
TW202019439A (zh) 2020-06-01
WO2020016408A1 (fr) 2020-01-23
GEP20237532B (en) 2023-08-25
HUE069700T2 (hu) 2025-04-28
EP3823588A1 (fr) 2021-05-26
CL2021000083A1 (es) 2021-07-30
PL3823588T3 (pl) 2025-03-31
MX2021000763A (es) 2021-03-29
EP3823588B1 (fr) 2024-10-23
KR20210034036A (ko) 2021-03-29
CA3106495C (fr) 2023-08-08
ES2991941T3 (es) 2024-12-05
AU2019306315A1 (en) 2021-02-11
SI3823588T1 (sl) 2025-04-30
CR20210023A (es) 2021-02-22
EP4473977A2 (fr) 2024-12-11
FI3823588T3 (fi) 2024-12-27
MD3823588T2 (ro) 2025-04-30
CN119345141A (zh) 2025-01-24
PH12021550037A1 (en) 2021-09-27
TWI831808B (zh) 2024-02-11
JOP20210003A1 (ar) 2021-01-10
MY200586A (en) 2024-01-04
PE20210929A1 (es) 2021-05-19
PT3823588T (pt) 2024-10-31
CN112423735A (zh) 2021-02-26
ECSP21001232A (es) 2021-02-26
CO2021000115A2 (es) 2021-01-29
LT3823588T (lt) 2024-11-11
NZ771968A (en) 2025-05-02
EA202190269A1 (ru) 2021-06-15
AR117612A1 (es) 2021-08-18
HRP20250037T1 (hr) 2025-03-14
AU2019306315B2 (en) 2023-03-09
RS66288B1 (sr) 2025-01-31
BR112021000440A2 (pt) 2021-04-06
SG11202100181YA (en) 2021-02-25
NI202100002A (es) 2021-06-22
GEAP202315564A (en) 2023-05-10
EP4473977A3 (fr) 2025-03-05

Similar Documents

Publication Publication Date Title
EP4072520C0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CABOTEGRAVIR
EP3641771A4 (en) PHARMACEUTICAL COMPOSITIONS
EP3454899C0 (en) PHARMACEUTICAL COMPOSITION
DK3297605T3 (da) Topiske, farmaceutiske sammesætninger
KR102281667B9 (ko) 아트로핀 약학 조성물 (atropine pharmaceutical compositions)
DK3655017T3 (da) Farmaceutisk sammensætning
EP4233846C0 (en) PHARMACEUTICAL FORMULATIONS
EP3661489A4 (en) COMPOSITION OF FLOTTABLE PHARMACEUTICAL MICROCAPSULE
DK3412660T3 (da) Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme
EP4289478C0 (en) PHARMACEUTICAL COMPOSITION OF EDARAVONE
ES2850277R1 (es) Composiciones de administración farmacéutica y usos de las mismas
HUE071411T2 (hu) 2-{4-[N-(5,6-difenilpirazin-2-il)-N-izopropilamino]butiloxi}-N-(metilszulfonil)-acetamidot tartalmazó szilárd gyógyászati készítmény
EP3868371A4 (en) Novel pharmaceutical composition
EP3583943A4 (en) PHARMACEUTICAL COMPOSITION
EP4037659C0 (en) PHARMACEUTICAL COMPOSITION CONTAINING ENZALUTAMIDE
EP3746080A4 (en) PHARMACEUTICAL FORMULATIONS
EP3383371C0 (en) PHARMACEUTICAL FORMULATION
DK3908321T3 (da) Farmaceutisk sammensætning
EP3646867C0 (en) PHARMACEUTICAL COMPOSITION
ME03033B (me) Peptidi derivati ezrina 1 njihove farmaceutske kompozicije
DK4056557T3 (da) Benzazepinderivater nyttige som medikamenter
EP3727485C0 (en) PHARMACEUTICAL COMPOSITION
PT3949952T (pt) Composição farmacêutica
EP3651800C0 (en) HYDROCOMPRESSED PHARMACEUTICAL FORMULATIONS
EP3592350A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USES